Current status of clinical research with new anti-diabetic drugs

被引：0
|
作者：
Oyama, Junichi [1 ]
Node, Koichi [2 ]
机构：
[1] Saga Univ, Sch Med, Dept Circulat Regulat, Saga, Japan
[2] Saga Univ, Sch Med, Dept Cardiovasc Med, Saga, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2017年 / 133卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
2-JSC-2
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] New approaches in research and development of anti-diabetic drugs: an industry perspective
    Maas, Jochen
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (04) : 109 - 112
  • [2] Special focus on the new anti-diabetic drugs
    Agewall, Stefan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 265 - 266
  • [3] Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
    Piazzolla, Giuseppina
    Vozza, Alfredo
    Volpe, Sara
    Bergamasco, Alessandro
    Triggiani, Vincenzo
    Lisco, Giuseppe
    Falconieri, Michela
    Tortorella, Cosimo
    Solfrizzi, Vincenzo
    Sabba, Carlo
    OPEN MEDICINE, 2022, 17 (01): : 1203 - 1215
  • [4] Anti-diabetic drugs and hypoglycemia
    Consoli, Agostino
    Di Fulvio, Patrizia
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (12) : 9S - 14S
  • [5] ORAL ANTI-DIABETIC DRUGS
    BALLY, C
    ASSAL, JP
    THERAPEUTISCHE UMSCHAU, 1979, 36 (11) : 1000 - 1003
  • [6] Anti-diabetic drugs - a new perspective to prevent inflammation?
    Bickel, M
    Lottaz, D
    Diem, P
    Beleznay, Z
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A496 - A496
  • [7] Anti-diabetic drugs and NASH: from current options to promising perspectives
    Smati, Sarra
    Canivet, Clemence M.
    Boursier, Jerome
    Cariou, Bertrand
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (08) : 813 - 825
  • [8] THE COST OF NEW ORAL ANTI-DIABETIC DRUGS IN CANADA AND INTERNATIONALLY
    Bosnic, N.
    Zhang, Y.
    O'Shea, B.
    Lungu, E.
    VALUE IN HEALTH, 2018, 21 : S81 - S81
  • [9] A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
    Yaribeygi, Habib
    Atkin, Stephen L.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (03) : 328 - 334
  • [10] Cardiovascular safety of anti-diabetic drugs
    Kumar, R.
    Kerins, D. M.
    Walther, T.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (01) : 32 - 43
12345